New trends in immunosuppression and immunotherapy.
In the past years, research on immune regulation has exploded thanks to the re-emergence of T suppressor cells (Ts), now coined as regulatory T cells (Tregs). It has been established that different populations of Tregs exist in the immune system, and the generation, mechanism of suppression and the cellular and molecular targets of Tregs are being unraveled. This will lead to new opportunities for immune intervention to treat autoimmune disease and to achieve clinical transplantation tolerance. The scientific progress in the field of translational medicine was presented at the 7th International Conference on New Trends in Immunosuppression and Immunotherapy in Berlin in February 2006. In this special issue of International Immunopharmacology, several papers submitted to this congress will highlight some of the advances in this burgeoning field of translational medicine.
Jiang
Shuiping
S
Immunoregulation, Department of Nephrology and Transplantation, King's College London, Guy's Hospital, London SE1 9RT, United Kingdom.
Lombardi
Giovanna
G
D019264:Adoptive Transfer; D001327:Autoimmune Diseases / Q000628:therapy; D006801:Humans; D007108:Immune Tolerance / Q000276:immunology; D007165:Immunosuppression Therapy / Q000639:trends*; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007167:Immunotherapy / Q000639:trends*; D008213:Lymphocyte Activation / Q000187:drug effects; D039904:Pluripotent Stem Cells / Q000637:transplantation; D050378:T-Lymphocytes, Regulatory / Q000187:drug effects / Q000276:immunology / Q000637:transplantation
D007166:Immunosuppressive Agents